Walden International

Venture Capital Active Bengaluru, India Est. 1984
Last updated 2026-06-18
Portfolio
4
in our dataset
Rounds participated
7
Rounds led
0
Rounds' value
$176.0M
total disclosed, rounds participated
Stages

About

Walden International is a global venture capital firm founded in 1984 and headquartered in San Francisco. It invests in early- to growth-stage technology companies, with a strong focus on semiconductors, electronics, software, and digital media. Walden is known for its cross-border investment strategy, particularly in the U.S. and Asia, helping startups expand internationally

Portfolio · 4

Investment activity

3 portfolio exits on record.

Portfolio by sector

Business Software3
Energy Tech1

Q&A

What is Walden International's most recent exit?
Walden International's most recent exit was Actelis Networks, which went public on NASDAQ in May 2022 with a valuation of $70M.
Which sectors does Walden International primarily focus on for investments?
Walden International shows a concentration in Business Software and Energy Tech, with 3 portfolio companies in Business Software and 1 in Energy Tech.
Can you name a notable public exit for Walden International in the energy sector?
Walden International had a notable public exit with SolarEdge Technologies, which went public on NASDAQ in March 2015 with a valuation of $685M.
What is Walden International's most recent portfolio company addition?
Walden International added LightBits Labs to its portfolio in March 2019.
What is the investment stage breakdown for Walden International's rounds?
Walden International has participated in 1 A Round, 1 B Round, 1 C Round, 1 D Round, 2 E Rounds, and 1 G Round.
Which company did Walden International exit through acquisition?
Walden International exited Zend Technologies through an acquisition by Rogue Wave in October 2015.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitewaldenintl.com/

Identifiers & details

Founded1984

Radar intelligence

Patents

EPO3